Silphium Asset Management LTD Cyma Bay Therapeutics, Inc. Transaction History

Silphium Asset Management LTD

  • $280 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 30, 2025
SELL
$6.54 - $11.74 $78,558 - $141,020
-12,012 Closed
0 $0
Q2 2018

Jan 30, 2025
SELL
$10.66 - $14.38 $213,200 - $287,600
-20,000 Reduced 62.48%
12,012 $161 Million
Q1 2018

Jan 30, 2025
BUY
$9.0 - $15.16 $288,108 - $485,301
32,012 New
32,012 $416 Million

Others Institutions Holding CBAY

# of Institutions
6
Shares Held
1.82M
Call Options Held
0
Put Options Held
0
View Full List

About CymaBay Therapeutics, Inc.

CBAY Quotes by TradingView
  • Ticker CBAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,677,904
  • Description
  • CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...
More about CBAY
Track This Portfolio

Track Silphium Asset Management LTD Portfolio

Follow Silphium Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silphium Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Silphium Asset Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email